CENCORA: FORMERLY AMERISOURCEBERGEN
Cencora is a leading global pharmaceutical solutions organization centered on improving the lives of people and animals around the world. We partner with pharmaceutical innovators across the value chain to facilitate and optimize market access to therapies. Care providers depend on us for the secure, reliable delivery of pharmaceuticals, healthcare products, and solutions. Our 46,000+ worldwide team members contribute to positive health outcomes through the power of our purpose: We are united in our responsibility to create healthier futures. Cencora is ranked #11 on the Fortune 500 and #24 on the Global Fortune 500 with more than $200 billion in annual revenue. Learn more at www.cencora.com
CENCORA CELL AND GENE THERAPY EVENTS
Groundbreaking gene therapies are paving the path to a healthier tomorrow. Cencora will be attending an exciting series of industry conferences, and our experts are prepared to discuss your advanced therapies supply chain and commercialization challenges.
We encourage you to network with us in person, attend our educational and interactive sessions and learn more about our integrated solutions that will help you position your therapies for success. Visit our website today to view our cell and gene therapy events.
CONTACT INFORMATION
Cencora
1 W 1st Ave.
Conshohocken, PA 19428
UNITED STATES
FEATURED INSIGHTS
-
Patient access depends on a well-planned channel strategy. Explore key considerations for optimizing distribution, logistics, and patient support in the evolving cell and gene therapy landscape.
-
The FDA's new FAQ offers crucial insights into best practices, from regulatory meetings to quality control and preclinical studies. Dive in for expert guidance.
-
Understanding the intricacies of cell and gene therapy naming conventions can be confusing but necessary for effectively navigating the development pathway to bring these advanced therapies to market.
GET MORE DETAILS ON OUR SOLUTIONS
-
Explore the latest market trends and the nuances of various cell and gene therapy modalities, along with the logistical considerations necessary to safeguard product quality and safety.
EXPLORE OUR THOUGHT LEADERSHIP
Explore the latest insights from the Cencora team.
WEBINARS
-
Q&A Interview: Navigating The Launch Of ATMPs In Europe
Dive into this overview of the evolving regulatory landscape and better understand the importance of proactive planning, collaboration, and expert guidance in navigating the ATMPs ecosystem in Europe.
-
Streamlining Patient Access To Cell And Gene Therapies
Learn about the obstacles patients encounter when seeking CGTs and explore how technology and patient services can empower manufacturers and clinical teams to help patients overcome barriers.
-
Webinar: Reimbursement Methods For Sustainable CGT Business Models
Learn more about the key features of successful innovative pricing and reimbursement models as well as outcomes-based agreements and the ways to advance those strategies for cell and gene therapies.
BLOGS
-
Expanding Patient Access To Cell And Gene Therapies: Optimizing Channel Strategy
Rare disease innovation demands robust channel strategies for patient access. Learn how a patient-centric approach, logistical solutions, and strong partnerships are key to successful patient access.
-
Navigating The CGT Landscape: Key Takeaways From The FDA's New FAQ
The FDA's new FAQ on cell and gene therapy offers a roadmap for developers. Review key insights from the document, including the importance of early engagement with the FDA, CMC considerations, and more.
-
Unraveling The Complexity Of Cell Therapy: Advancements And Challenges
Cell therapy has emerged as a powerful tool for addressing critical medical challenges, but its rapid evolution necessitates a clear regulatory framework and consistent terminology.